Studie 73
-
Studie 73
GSK har annonceret dette på clinical trials:
Phase II Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)
This study is not yet open for participant recruitment.
Verified January 2012 by GlaxoSmithKline
First Received on January 19, 2012. Last Updated on January 26, 2012
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind